76 related articles for article (PubMed ID: 10445270)
21. [Monitoring of anticoagulants of secondary haemostasis].
Schuster B
Hamostaseologie; 2009 Aug; 29(3):268-73. PubMed ID: 19644600
[TBL] [Abstract][Full Text] [Related]
22. [Cerebral infarct in a patient with diabetes mellitus].
Mora C; Macía M; García J; Navarro JF
Nefrologia; 2001; 21(4):418-20. PubMed ID: 11816523
[No Abstract] [Full Text] [Related]
23. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
[TBL] [Abstract][Full Text] [Related]
24. [Multivariate analysis for the understanding of typical diabetic hemostasis criteria. 1: Plasma markers].
Syrbe G; Schröder H; Keil E; Jütte A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):717-23. PubMed ID: 1709905
[TBL] [Abstract][Full Text] [Related]
25. [Effect of the heparin-lysine complex on the hemostatic and insular systems].
Ul'ianov AM; Liapina LA; Pastorova VE; Obergan TIu; Shubina TA
Izv Akad Nauk Ser Biol; 2004; (5):581-4. PubMed ID: 15559137
[TBL] [Abstract][Full Text] [Related]
26. [Status of the hemostasis system in periodontitis in patients with insulin-dependent diabetes mellitus as criteria of disease severity and treatment efficacy].
Mingazov GG; Faĭzullina DB; Aminova ET
Stomatologiia (Mosk); 2001; 80(1):77-9. PubMed ID: 11236155
[TBL] [Abstract][Full Text] [Related]
27. [Diabetes mellitus and changes in hemostasis: study of the fibrinolytic response of insulin-dependent patients without vascular disease].
García Pérez AA; Marco Vera P; Mompel Sanjuan A; Abad Gosalbez A
Rev Clin Esp; 1989 Feb; 184(3):128-30. PubMed ID: 2717790
[TBL] [Abstract][Full Text] [Related]
28. Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon.
Ceriello A; Quatraro A; Dello Russo P; Marchi E; Barbanti M; Milani MR; Giugliano D
Thromb Haemost; 1990 Aug; 64(1):104-7. PubMed ID: 2274914
[TBL] [Abstract][Full Text] [Related]
29. [New anticoagulants for secondary haemostasis--anti IIa inhibitors].
Nowak G
Hamostaseologie; 2009 Aug; 29(3):256-9. PubMed ID: 19644604
[TBL] [Abstract][Full Text] [Related]
30. Heparins in diabetic microangiopathy: rationale and preliminary clinical results.
van Der Woude FJ
Haemostasis; 1999 Dec; 29 Suppl S1():61-7. PubMed ID: 10629405
[TBL] [Abstract][Full Text] [Related]
31. [Action of doxorubicin and a doxorubicin-heparin complex on the growth and metastasis of experimental tumors and the hemostatic system indices].
Kalishevskaia TM; Bashkov GV; Repina NIu; Shpilevaia MV; Modina LS
Eksp Onkol; 1988; 10(4):59-62. PubMed ID: 3181077
[TBL] [Abstract][Full Text] [Related]
32. Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.
Uzun G; Onem Y; Hatipoglu M; Turhan V; Mutluoglu M; Ay H
Scand J Infect Dis; 2013 Jan; 45(1):73-6. PubMed ID: 22746695
[TBL] [Abstract][Full Text] [Related]
33. [Oral contraceptives and diabetes].
Bargero G; Capra Marzani M; Fasano M; Rosso A
Minerva Med; 1986 May; 77(19):839-42. PubMed ID: 3520394
[TBL] [Abstract][Full Text] [Related]
34. [Changes in thrombocytic hemostasis in patients with diabetic glomerulosclerosis].
Belitskaia GA; Lapchinskaia II; Donish RM; Ishchenko VM; Fedorova NE; Glebova AN; Kozlenko VM; Korobko VF; Sobolevskaia NV
Vrach Delo; 1991 Jul; (7):66-9. PubMed ID: 1771840
[TBL] [Abstract][Full Text] [Related]
35. Serum lipoprotein (a) levels in patients with diabetic foot lesions.
Unlühizarci K; Muhtaroğlu S; Kabak S; Bayram F; Keleştimur F
Diabetes Res Clin Pract; 2006 Feb; 71(2):119-23. PubMed ID: 16122830
[TBL] [Abstract][Full Text] [Related]
36. Diabetic thigh muscle infarction in association with antiphospholipid antibodies.
Palmer GW; Greco TP
Semin Arthritis Rheum; 2001 Feb; 30(4):272-80. PubMed ID: 11182027
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
Oguejiofor OC; Odenigbo CU; Oguejiofor CB
Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
[TBL] [Abstract][Full Text] [Related]
38. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
39. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
[TBL] [Abstract][Full Text] [Related]
40. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
